{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/delivering-rapid-results-early-phase-cro-partner#webpage",
"url": "https://www.fortrea.com/insights/delivering-rapid-results-early-phase-cro-partner",
"name": "Delivering rapid results as an early-phase CRO partner ",
"description": "This case study demonstrates how clinical trial start up services were optimized through a hybrid outsourcing model to manage high-volume regulatory submissions and accelerate study initiation across multiple regions. The approach focused on improving study start up management in clinical trials by combining centralized oversight with localized regulatory expertise to support country-specific requirements, including ethics committee submissions and regulatory approvals. By leveraging a functional service provider outsourcing model, the strategy enabled efficient clinical trial submission management, reduced delays, and improved coordination across stakeholders. The case study highlights how localized regulatory submissions in clinical trials, supported by structured processes and scalable resources, can optimize clinical trial startup timelines and enhance overall execution. Through integrated planning and flexible outsourcing, this approach demonstrates how sponsors can streamline regulatory workflows and achieve faster, more efficient study start up."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Delivering rapid results as an early-phase CRO partner",
"item": "https://www.fortrea.com/insights/creative-problem-solving-supports-site-recruitment-complex-sepsis-study"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/delivering-rapid-results-early-phase-cro-partner#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/delivering-rapid-results-early-phase-cro-partner#webpage"
},
"headline": "Early Phase CRO Services for Rapid Phase 1 Clinical Trials Delivery | Fortrea Case Study",
"description": "This case study demonstrates how clinical trial start up services were optimized through a hybrid outsourcing model to manage high-volume regulatory submissions and accelerate study initiation across multiple regions. The approach focused on improving study start up management in clinical trials by combining centralized oversight with localized regulatory expertise to support country-specific requirements, including ethics committee submissions and regulatory approvals. By leveraging a functional service provider outsourcing model, the strategy enabled efficient clinical trial submission management, reduced delays, and improved coordination across stakeholders. The case study highlights how localized regulatory submissions in clinical trials, supported by structured processes and scalable resources, can optimize clinical trial startup timelines and enhance overall execution. Through integrated planning and flexible outsourcing, this approach demonstrates how sponsors can streamline regulatory workflows and achieve faster, more efficient study start up.",
"genre": "Case Study",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-11-26",
"dateModified": "2025-11-26",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-11/early-phase-cro-rapid-results.pdf",
"encodingFormat": "application/pdf"
}
}
]
}